Safety and Side Effects of Ayahuasca in Humans-An Overview Focusing on Developmental Toxicology

Journal of Psychoactive Drugs

Volumn 45, Issue 1, 2013, Pages 68-78

  Guimarães dos Santos, Rafael ^a  

^a International Center for Ethnobotanical Education Research and Service   (Netherlands)

Author keywords

ayahuasca; hallucinogens; psychopharmacology; tolerability; toxicology

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; AYAHUASCA; BETA CARBOLINE; CANNABIS; CYTOCHROME P450 2D1; DEXTROMETHORPHAN; HARMINE; MESCALINE; MONOAMINE OXIDASE INHIBITOR; N, N DIMETHYLTRYPTAMINE; PSILOCYBINE; PSYCHEDELIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN; UNCLASSIFIED DRUG;

ANXIETY DISORDER; ARTICLE; CD4 LYMPHOCYTE COUNT; CHEMICAL INTERACTION; DEVELOPMENTAL TOXICITY; DISORIENTATION; DRUG MEGADOSE; HUMAN; LOW DRUG DOSE; NAUSEA AND VOMITING; NEUROTOXICITY; NONHUMAN; PSYCHOSIS; SEROTONIN SYNDROME; SIDE EFFECT;

ADOLESCENT; ADULT; ANIMALS; BANISTERIOPSIS; BEVERAGES; CEREMONIAL BEHAVIOR; CHILD; FEMALE; HALLUCINOGENS; HUMANS; PLANT EXTRACTS; PREGNANCY; PSYCHOTROPIC DRUGS; SPECIES SPECIFICITY; TIME FACTORS;

EID: 84874532432     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2013.763564     Document Type: Article

References (139)

1. América Noticias. 2012. Policía confirmó que joven estadounidense fue asesinado durante sesión de Ayahuasca en Puerto Maldonado [Police confirms that a young North American was murdered in an ayahuasca session in Puerto Maldonado]. http://www.americatv.com.pe/portal/noticias/actualidad/polic-confirm-que-joven-estadounidense-fue-asesinado-durante-sesi-n-de-ayahuasca-en-puert (http://www.americatv.com.pe/portal/noticias/actualidad/polic-confirm-que-joven-estadounidense-fue-asesinado-durante-sesi-n-de-ayahuasca-en-puert)
2. Andrade, E.N., Brito, G.S., Andrade, E.O., Neves, E.S., McKenna, D., Cavalcante, J.W., Okimura, L., Grob, C. and Callaway, J.C. 2004. "Farmacologia humana da hoasca: estudos clínicos (avaliação clínica comparativa entre usuários do chá hoasca por longo prazo e controles; avaliação fisiológica dos efeitos agudos pós-ingestão do chá hoasca) [Human pharmacology of hoasca: clinical studies (comparative clinical assessment between long-term consumers of the hoasca tea and controls; physiological assessment of acute effects after ingestion of the hoasca tea]". In O uso ritual da ayahuasca [The ritual use of ayahuasca], Second, Edited by: Labate, B.C. and Araújo, W.S. Campinas: Mercado de Letras.
3. Aricioglu-Kartal, F., Kayir, H. and Tayfun Uzbay, I. 2003. Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats. Life Sciences, 73(18): 2363-71.
4. Barbanoj, M.J., Riba, J., Clos, S., Giménez, S., Grasa, E. and Romero, S. 2008. Daytime ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers. Psychopharmacology, 196(2): 315-26.
5. Barbosa, P.C., Giglio, J.S. and Dalgalarrondo, P. 2005. Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil. Journal of Psychoactive Drugs, 37(2): 193-201.
6. Barbosa, P.C., Mizumoto, S., Bogenschutz, M.P. and Strassman, R.J. 2012. Health status of ayahuasca users. Drug Testing & Analysis, 4(7-8): 601-09.
7. Barbosa, P.C., Cazorla, I.M., Giglio, J.S. and Strassman, R. 2009. A six-month prospective evaluation of personality traits, psychiatric symptoms and quality of life in ayahuasca-naïve subjects. Journal of Psychoactive Drugs, 41(3): 205-12.
8. Bouso, J.C. & Riba, J. 2011. An overview of the literature on the pharmacology and neuropsychiatric long term effects of ayahuasca. In: R.G. dos Santos (Ed.) The Ethnopharmacology of Ayahuasca. Trivandrum: Transworld Research Network. http://www.trnres.com/ebook/uploads/rafael/T_12998350813%20Rafael.pdf
9. Bouso, J.C., González, D., Fondevila, S., Cutchet, M., Fernández, X., Barbosa, P.C.R., Alcázar-Córcoles, M.Á., Araújo, W.S., Barbanoj, M.J., Fábregas, J.M. and Riba, J. 2012. Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: A longitudinal study. PLoS ONE, 7(8): e42421
10. Bouso, J.C., Fábregas, J.M., González, D., Fondevila, S., Fernández, X., Cutchet, M. and Alcázar-Córcoles, M.Á. 2011. "Long-term effects of ritual use of ayahuasca on mental health". In The Internationalization of Ayahuasca, Edited by: Labate, B.C. and Jungaberle, H. Zurich/Berlin: Lit Verlag.
11. Boyer, E.W. and Shannon, M. 2005. The serotonin syndrome. New England Journal of Medicine, 352(11): 1112-20.
12. Brierley, D.I. and Davidson, C. 2013. Harmine augments electrically evoked dopamine efflux in the nucleus accumbens shell. Journal of Psychopharmacology, 27(1): 98-108.
13. Brierley, D.I. and Davidson, C. 2012. Developments in harmine pharmacology-Implications for ayahuasca use and drug-dependence treatment. Progress in Neuropsychopharmacology & Biological Psychiatry, 39(2): 263-72.
14. Brush, D.E., Bird, S.B. and Boyer, E.W. 2004. Monoamine oxidase inhibitor poisoning resulting from internet misinformation on illicit substances. Journal of Toxicology/Clinical Toxicology, 42(2): 191-5.
15. Callaway, J.C. 2005. Fast and slow metabolizers of Hoasca. Journal of Psychoactive Drugs, 37(2): 157-61.
16. Callaway, J.C. 2002. "Fitoquímica e neurofarmacologia da ayahuasca [Ayahuasca phytochemistry and neuropharmacology]". In Ayahuasca, Alucinógenos, Consciência e o Espírito da Natureza [Ayahuasca, Hallucinogens, Consciousness, and Spirit of Nature], Edited by: Metzner, R. Rio de Janeiro: Gryphus.
17. Callaway, J.C. and Grob, C.S. 1998. Ayahuasca preparations and serotonin reuptake inhibitors: A potential combination for severe adverse interactions. Journal of Psychoactive Drugs, 30(4): 367-69.
18. Callaway, J.C., Grob, C.S., McKenna, D.J., Nichols, D.E., Shulgin, A. and Tupper, K.W. 2006. A demand for clarity regarding a case report on the ingestion of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in an ayahuasca preparation. Journal of Analytical Toxicology, 30(6): 406-07.
19. Callaway, J.C., McKenna, D.J., Grob, C.S., Brito, G.S., Raymon, L.P., Poland, R.E., Andrade, E.N., Andrade, E.O. and Mash, D.C. 1999. Pharmacokinetics of hoasca alkaloids in healthy humans. Journal of Ethnopharmacology, 65(3): 243-56.
20. Callaway, J.C., Raymon, L.P., Hearn, W.L., McKenna, D.J., Grob, C.S., Brito, G.S. and Mash, D.C. 1996. Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca. Journal of Analytical Toxicology, 20(6): 492-97.
21. Callaway, J.C., Airaksinen, M.M., McKenna, D.J., Brito, G.S. and Grob, C.S. 1994. Platelet serotonin uptake sites increased in drinkers of ayahuasca. Psychopharmacology, 116(3): 385-87.
22. Cárdenas, M.Á. 2011. Sueco que estuvo en coma luego de tomar ayahuasca se recupera [Swede who was in a coma after taking ayahuasca recovers]. http://elcomercio.pe/peru/695574/noticia-sueco-que-estuvo-coma-luego-tomar-ayahuasca-se-recupera_1 (http://elcomercio.pe/peru/695574/noticia-sueco-que-estuvo-coma-luego-tomar-ayahuasca-se-recupera_1)
23. CityTv. 2010. El ceremonial Yagé llevó a la muerte a un hombre de 33 años [The Yagé ceremonial led to the death of a 33 year old man]. http://www.citytv.com.co/videos/287620/el-ceremonial-yage-llevo-a-la-muerte-a-un-hombre-de-33-anos (http://www.citytv.com.co/videos/287620/el-ceremonial-yage-llevo-a-la-muerte-a-un-hombre-de-33-anos)
24. Colombia Reports. 2011. Two die in north-Colombia ayahuasca ceremony. http://colombiareports.com/colombia-news/news/18348-2-die-in-north-colombia-ayahuasca-ceremony.html (http://colombiareports.com/colombia-news/news/18348-2-die-in-north-colombia-ayahuasca-ceremony.html)
25. da Silveira, D.X., Grob, C.S., Dobkin de Rios, M., Lopez, E., Alonso, L.K., Tacla, C. and Doering-Silveira, E. 2005. Ayahuasca in adolescence: A preliminary psychiatric assessment. Journal of Psychoactive Drugs, 37(2): 129-33.
26. de Araujo, D.B., Ribeiro, S., Cecchi, G.A., Carvalho, F.M., Sanchez, T.A., Pinto, J.P., de Martinis, B.S., Crippa, J.A., Hallak, J.E. and Santos, A.C. 2011. Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion. Human Brain Mapping, 33(11): 2550-60.
27. de la Torre, R. and Farré, M. 2004. Neurotoxicity of MDMA (ecstasy): The limitations of scaling from animals to humans. Trends in Pharmacological Sciences, 25(10): 505-08.
28. de la Torre, R., Puerta, E. and Aguirre, N. 2009. Comment on the letter by Green, Gabrielsson, Marsden, and Fone, MDMA: on the translation from rodent to human dosing. Psychopharmacology, 204(2): 379-80.
29. de, Dobkin, Rios, M., Grob, C.S., Lopez, E., da Silviera, D.X., Alonso, L.K. and Doering-Silveira, E. 2005. Ayahuasca in adolescence: Qualitative results. Journal of Psychoactive Drugs, 37(2): 135-39.
30. Doering-Silveira, E., Lopez, E., Grob, C.S., Dobkin de Rios, M., Alonso, L.K., Tacla, C., Shirakawa, I., Bertolucci, P.H. and da Silveira, D.X. 2005a. Ayahuasca in adolescence: A neuropsychological assessment. Journal of Psychoactive Drugs, 37(2): 123-28.
31. Doering-Silveira, E., Grob, C.S., Dobkin de Rios, M., Lopez, E., Alonso, L.K., Tacla, C. and da Silveira, D.X. 2005b. Report on psychoactive drug use among adolescents using ayahuasca within a religious context. Journal of Psychoactive Drugs, 37(2): 141-44.
32. dos Santos, R.G. In press(a). A critical evaluation of reports associating ayahuasca with life-threatening adverse reactions. Journal of Psychoactive Drugs,
33. dos Santos, R.G. In press(b). "Posibles riesgos asociados al consumo de ayahuasca [Possible risks associated with the use of ayahuasca]". In Ayahuasca y Salud [Ayahuasca and Health], Edited by: Labate, B.C. and Bouso, J.C. Barcelona: Los Libros de La Liebre de Marzo.
34. dos Santos, R.G. 2011a. Ayahuasca: Physiological and subjective effects, comparison with d-amphetamine, and repeated dose assessment. Doctoral thesis, Universitat Autònoma de Barcelona, Barcelona, Spain. https://www.educacion.gob.es/teseo/mostrarRef.do?ref=959049 (http://https://www.educacion.gob.es/teseo/mostrarRef.do?ref=959049)
35. dos Santos, R.G. 2011b. Possible risks and interactions of the consumption of ayahuasca and cannabis in humans. In: R.G. dos Santos (Ed.) The Ethnopharmacology of Ayahuasca. Trivandrum: Transworld Research Network. http://www.trnres.com/ebook/uploads/rafael/T_12998352676%20Rafael.pdf
36. dos Santos, R.G. 2010a. The pharmacology of ayahuasca: A review. Brasília Médica 47 (2): 188-95. http://www.ambr.org.br/portal/arquivos/12.pdf (http://www.ambr.org.br/portal/arquivos/12.pdf)
37. dos Santos, R.G. 2010b. Toxicity of chronic ayahuasca administration to the pregnant rat: How relevant it is regarding the human, ritual use of ayahuasca?. Birth Defects Research. Part B, Developmental and Reproductive Toxicology, 89(6): 533-35.
38. dos Santos, R.G. & Strassman, R.J. 2011. Ayahuasca and psychosis. In: R.G. dos Santos (Ed.) The Ethnopharmacology of Ayahuasca. Trivandrum: Transworld Research Network. http://www.trnres.com/ebook/uploads/rafael/T_12998353067%20Rafael.pdf (http://www.trnres.com/ebook/uploads/rafael/T_12998353067%20Rafael.pdf)
39. dos Santos, R.G., Grasa, E., Valle, M., Ballester, M.R., Bouso, J.C., Nomdedéu, J.F., Homs, R., Barbanoj, M.J. and Riba, J. 2012. Pharmacology of ayahuasca administered in two repeated doses. Psychopharmacology, 219(4): 1039-53.
40. dos Santos, R.G.; Moraes, C.C. & Holanda, A. 2006. Ayahuasca e redução do uso abusivo de psicoativos: Eficácia terapêutica? [Ayahuasca and reduction of the abusive use of psychoactives: Therapeutic efficacy?]. Psicologia: Teoria e Pesquisa 22 (3): 363-70. http://www.scielo.br/pdf/ptp/v22n3/14.pdf (http://www.scielo.br/pdf/ptp/v22n3/14.pdf)
41. dos Santos, R.G., Valle, M., Bouso, J.C., Nomdedéu, J.F., Rodríguez-Espinosa, J., McIlhenny, E.H., Barker, S.A., Barbanoj, M.J. and Riba, J. 2011. Autonomic, neuroendocrine and immunological effects of ayahuasca. A comparative study with d-amphetamine. Journal of Clinical Psychopharmacology, 31(6): 717-26.
42. dos Santos, R.G., Landeira-Fernandez, J., Strassman, R.J., Motta, V. and Cruz, A.P. 2007. Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. Journal of Ethnopharmacology, 112(3): 507-13.
43. 2A receptor in C57BL/6N mice. Psychopharmacology, 215(3): 581-93.
44. El Comercio. 2012. Curandero fue recluido en penal tras confesar que causó muerte de turista [Curandero was held in prison after confessing that he had caused the death of a tourist]. http://elcomercio.pe/actualidad/1469956/noticia-curandero-fue-recluido-penal-confesar-que-causo-muerte-turista (http://elcomercio.pe/actualidad/1469956/noticia-curandero-fue-recluido-penal-confesar-que-causo-muerte-turista)
45. El Comercio. 2010. Turista sueco sufrió una grave intoxicación por ingerir ayahuasca [Swedish tourist suffered a severe poisoning from ingesting ayahuasca]. http://elcomercio.pe/peru/691501/noticia-turista-sueco-sufrio-grave-intoxicacion-ingerir-ayahuasca (http://elcomercio.pe/peru/691501/noticia-turista-sueco-sufrio-grave-intoxicacion-ingerir-ayahuasca)
46. El Espectador. 2011. Dos muertos tras consumir yagé en Santander [Two dead after consuming yagé in Santander]. http://www.elespectador.com/noticias/nacional/articulo-292147-dos-muertos-tras-consumir-yage-santander (http://www.elespectador.com/noticias/nacional/articulo-292147-dos-muertos-tras-consumir-yage-santander)
47. Fábregas, J.M., González, D., Fondevila, S., Cutchet, M., Fernández, X., Barbosa, P.C., Alcázar-Córcoles, M.Á., Barbanoj, M.J., Riba, J. and Bouso, J.C. 2010. Assessment of addiction severity among ritual users of ayahuasca. Drug and Alcohol Dependence, 111(3): 257-61.
48. Farberov, S. 2012. Peruvian shaman confesses he buried body of U.S. teen who died from drinking hallucinogenic herbal brew at spiritual retreat. http://www.dailymail.co.uk/news/article-2202459/Kyle-Joseph-Nolan-death-Peruvian-shaman-confesses-buried-body-U-S-teen-spiritual-retreat.html?openGraphAuthor=%2Fhome%2Fsearch.html%3Fs%3D%26authornamef%3DSnejana%2BFarberov (http://www.dailymail.co.uk/news/article-2202459/Kyle-Joseph-Nolan-death-Peruvian-shaman-confesses-buried-body-U-S-teen-spiritual-retreat.html?openGraphAuthor=%2Fhome%2Fsearch.html%3Fs%3D%26authornamef%3DSnejana%2BFarberov)
49. Fernández, X. and Fábregas, J.M. "press. Experiencia de un tratamiento para las adicciones con ayahuasca en la Amazonia Brasileña [Experiment of a treatment for addictions using ayahuasca in the Brazilian Amazon]". In Ayahuasca y Salud [Ayahuasca and Health], Edited by: Labate, B.C. and Bouso, J.C. Barcelona: Los Libros de La Liebre de Marzo.
50. Fortunato, J.J., Réus, G.Z., Kirsch, T.R., Stringari, R.B., Fries, G.R., Kapczinski, F., Hallak, J.E., Zuardi, A.W., Crippa, J.A. and Quevedo, J. 2010a. Effects of β-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: Further evidence of antidepressant properties. Brain Research Bulletin, 81(4-5): 491-96.
51. Fortunato, J.J., Réus, G.Z., Kirsch, T.R., Stringari, R.B., Fries, G.R., Kapczinski, F., Hallak, J.E., Zuardi, A.W., Crippa, J.A. and Quevedo, J. 2010b. Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus. Journal of Neural Transmission, 117(10): 1131-37.
52. Fortunato, J.J., Réus, G.Z., Kirsch, T.R., Stringari, R.B., Stertz, L., Kapczinski, F., Pinto, J.P., Hallak, J.E., Zuardi, A.W., Crippa, J.A. and Quevedo, J. 2009. Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus. Progress in Neuropsychopharmacology & Biological Psychiatry, 33(8): 1425-3.
53. Frecska, E. 2007. "Therapeutic guidelines: Dangers and contraindications in therapeutic applications of hallucinogens". In Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments, Edited by: Winkelman, M.J. and Roberts, T.B. Vol. 1, Westport: Praeger.
54. Frecska, E., White, K.D. and Luna, L.E. 2004. Effects of ayahuasca on binocular rivalry with dichoptic stimulus alternation. Psychopharmacology, 173(1-2): 79-87.
55. Frecska, E., White, K.D. and Luna, L.E. 2003. Effects of the Amazonian psychoactive beverage ayahuasca on binocular rivalry: Interhemispheric switching or interhemispheric fusion?. Journal of Psychoactive Drugs, 35(3): 367-74.
56. Gable, R.S. 2007. Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Addiction, 102(1): 24-34.
57. Gomes, H. 2010. A encruzilhada do Daime [The crossroads of Daime]. http://www.istoe.com.br/reportagens/48304_A+ENCRUZILHADA+DO+DAIME+PARTE+1?pathImagens=&path=&actualArea=internalPage (http://www.istoe.com.br/reportagens/48304_A+ENCRUZILHADA+DO+DAIME+PARTE+1?pathImagens=&path=&actualArea=internalPage)
58. Green, A., King, M., Shortall, S. and Fone, K. 2012. Lost in translation: Preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans. British Journal of Pharmacology, 166(5): 1523-36.
59. Green, A.R., Gabrielsson, J., Marsden, C.A. and Fone, K.C. 2009. MDMA: On the translation from rodent to human dosing. Psychopharmacology, 204(2): 375-78.
60. Grob, C.S., McKenna, D.J., Callaway, J.C., Brito, G.S., Neves, E.S., Oberlaender, G., Saide, O.L., Labigalini, E., Tacla, C., Miranda, C.T., Strassman, R.J. and Boone, K.B. 1996. Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. Journal of Nervous and Mental Disease, 184(2): 86-94.
61. Halky, J.J. 1974. The effects of dextroamphetamine, dimethyltryptamine, lysergic acid diethylamide and tetrahydrocannabinol upon pregnancy and the offspring. Dissertation Abstracts International B, 34(12): 6137-8B.
62. Halpern, J.H., Sherwood, A.R., Hudson, J.I., Gruber, S., Kozin, D. and Pope, H.G. Jr. 2011. Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs. Addiction, 106(4): 777-86.
63. Halpern, J.H., Sherwood, A.R., Passie, T., Blackwell, K.C. and Ruttenber, A.J. 2008. Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament. Medical Science Monitor, 14(8): SR15-22.
64. Hilton, S.E., Maradit, H. and Möller, H.J. 1997. Serotonin syndrome and drug combinations: focus on MAOI and RIMA. European Archives of Psychiatry and Clinical Neuroscience, 247(3): 113-19.
65. Johnson, J. 2012. Sebastopol teen dead after Peruvian ritual. http://www.pressdemocrat.com/article/20120914/ARTICLES/120919770?tc=ar (http://www.pressdemocrat.com/article/20120914/ARTICLES/120919770?tc=ar)
66. Kamel, S.H., Ibrahim, T.M. and Hamza, S.M. 1971. Effect of harmine and harmaline hydrochloride on pregnancy in white rats. Zentralbl Veterinärmed A, 18(3): 230-03.
67. Kovner, G. 2012. Sebastopol teen died in Peru trying" to further open his mind". http://sebastopol.towns.pressdemocrat.com/2012/09/news/sebastopol-teen-died-in-peru-trying-to-further-open-his-mind/ (http://sebastopol.towns.pressdemocrat.com/2012/09/news/sebastopol-teen-died-in-peru-trying-to-further-open-his-mind/)
68. La FM. 2010. Medicina Legal avanza en trabajos para determinar causas de la muerte de un hombre tras consumir Yagé en un ritual [Forensic Medicine advances in the investigation of the cause of the death of a man after taking Yagé in a ritual]. http://www.lafm.com.co/noticias/bogot-y-cundinamarca/17-11-10/medicina-legal-avanza-en-trabajos-para-determinar-causas-de-l (http://www.lafm.com.co/noticias/bogot-y-cundinamarca/17-11-10/medicina-legal-avanza-en-trabajos-para-determinar-causas-de-l)
69. La Gaceta. 2011. Sueco tomó un brebaje y entró en coma [Swede took a beverage and entered in coma]. http://www.lagaceta.com.ar/nota/416570/Informaci%C3%B3n_General/Sueco-tomo-brebaje-entro-coma.html (http://www.lagaceta.com.ar/nota/416570/Informaci%C3%B3n_General/Sueco-tomo-brebaje-entro-coma.html)
70. La Republica 2011. Turista francés muere por sobredosis de ayahuasca [French tourist dies from overdose of ayahuasca]. http://www.larepublica.pe/26-11-2011/loreto-turista-frances-muere-por-sobredosis-de-ayahuasca#foto1 (http://www.larepublica.pe/26-11-2011/loreto-turista-frances-muere-por-sobredosis-de-ayahuasca#foto1)
71. La Republica. 2010. Polaco toma Ayahuasca y queda en coma [Polish man takes ayahuasca and enters in coma]. http://www.larepublica.pe/28-12-2010/polaco-toma-ayahuasca-y-queda-en-coma (http://www.larepublica.pe/28-12-2010/polaco-toma-ayahuasca-y-queda-en-coma)
72. Labate, B.C. 2011. Consumption of ayahuasca by children and pregnant women: Medical controversies and religious perspectives. Journal of Psychoactive Drugs, 43(1): 27-35.
73. Labate, B.C., Rose, I.S. and dos Santos, R.G. 2009. Ayahuasca Religions: A Comprehensive Bibliography and Critical Essays, Santa Cruz, CA: Multidisciplinary Association for Psychedelic Studies.
74. Labate, B.C., dos Santos, R.G., Strassman, R., Anderson, B. and Mizumoto, S. In press. "Efectos de la afiliación al Santo Daime sobre la dependencia a sustancias [Effect of Santo Daime membership on substance dependence]". In Ayahuasca y Salud, Edited by: Labate, B.C. and Bouso, J.C. Barcelona: Los Libros de La Liebre de Marzo. Ayahuasca and Health].
75. Labate, B.C., dos Santos, R.G., Anderson, B., Mercante, M. and Barbosa, P.C.R. 2010. "The treatment and handling of substance dependence with ayahuasca: Reflections on current and future research". In Ayahuasca, Ritual and Religion in Brazil, Edited by: Labate, B.C. and MacRae, E. London: Equinox.
76. Lima, F.A.S. and Tófoli, L.F. 2011. "An epidemiological surveillance system by the UDV: Mental health recommendations concerning the religious use of hoasca". In The Internationalization of Ayahuasca, Edited by: Labate, B.C. and Jungaberle, H. Zurich/Berlin: Lit Verlag.
77. Lima, F.; Naves, M.; Motta, J.; Migueli, J.; Brito, G. et al. 2002. Sistema de monitoramento psiquiátrico em usuários do chá hoasca [Psychiatric surveillance system in hoasca tea consumers]. Revista Brasileira de Psiquiatria 24 (Suppl. 2). http://dx.doi.org/10.1590/S1516-44462002000600014 (http://dx.doi.org/10.1590/S1516-44462002000600014)
78. Luna, L.E. 2011. Indigenous and mestizo use of Ayahuasca. An overview. In: R.G. dos Santos (Ed.) The Ethnopharmacology of Ayahuasca. Trivandrum: Transworld Research Network. http://www.trnres.com/ebook/uploads/rafael/T_12998349951%20Rafael.pdf (http://www.trnres.com/ebook/uploads/rafael/T_12998349951%20Rafael.pdf)
79. Lyvers, M. 2006. Recreational ecstasy use and the neurotoxic potential of MDMA: Current status of the controversy and methodological issues. Drug and Alcohol Review, 25(3): 269-76.
80. Mason, C. 2012. Father raises $8,300 to bring Sebastopol teen's body from Peru. PressDemocrat http://sebastopol.towns.pressdemocrat.com/2012/09/news/father-raises-8300-to-bring-sebastopol-teens-body-from-peru/ (http://sebastopol.towns.pressdemocrat.com/2012/09/news/father-raises-8300-to-bring-sebastopol-teens-body-from-peru/)
81. McIlhenny, E.H., Riba, J., Barbanoj, M.J., Strassman, R. and Barker, S.A. 2012. Methodology for determining major constituents of ayahuasca and their metabolites in blood. Biomedical Chromatography, 26(3): 301-13.
82. McIlhenny, E.H., Riba, J., Barbanoj, M.J., Strassman, R. and Barker, S.A. 2011. Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine. Biomedical Chromatography, 25(9): 970-84.
83. 3H-ketanserin. Journal of Neuroscience, 9(10): 3482-90.
84. Miwa, H., Kubo, T., Suzuki, A., Kihira, T. and Kondo, T. 2006. A species-specific difference in the effects of harmaline on the rodent olivocerebellar system. Brain Research, 1068(1): 94-101.
85. Mueller, M., Maldonado-Adrian, C., Yuan, J., McCann, U.D. and Ricaurte, G.A. 2012. "Studies of {+/-} 3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: Relationship to neuroprotection and neurotoxicity profile". In Journal of Pharmacology and Experimental Therapeutics doi:10.1124/jpet.112.201699
86. Mueller, M., Goodwin, A.K., Ator, N.A., McCann, U.D. and Ricaurte, G.A. 2011. Metabolism and disposition of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") in baboons after oral administration: Comparison to humans reveals marked differences. Journal of Pharmacology and Experimental Therapeutics, 338(1): 310-07.
87. Neto, J.S. 2009. Polícia de Goiás investiga morte de universitário após tomar chá do Santo Daime [The Police of Goiás State investigates the death of a university student after drinking the Santo Daime tea]. http://oglobo.globo.com/cidades/mat/2009/11/18/policia-de-goias-investiga-morte-de-universitario-apos-tomar-cha-do-santo-daime-914820561.asp (http://oglobo.globo.com/cidades/mat/2009/11/18/policia-de-goias-investiga-morte-de-universitario-apos-tomar-cha-do-santo-daime-914820561.asp)
88. O'Hearn, E. and Molliver, M.E. 1997. The olivocerebellar projection mediates ibogaine-induced degeneration of Purkinje cells: A model of indirect, trans-synaptic excitotoxicity. Journal of Neuroscience, 17(22): 8828-41.
89. O'Hearn, E. and Molliver, M.E. 1993. Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline. Neuroscience, 55(2): 303-10.
90. Oliveira, C.D.; Moreira, C.Q.; Spinosa, H. de S. & Yonamine, M. 2011. Neurobehavioral, reflexological and physical development of Wistar rat offspring exposed to ayahuasca during pregnancy and lactation. Revista Brasileira de Farmacognosia 21 (6): 1065-76. http://www.scielo.br/pdf/rbfar/v21n6/aop16311.pdf (http://www.scielo.br/pdf/rbfar/v21n6/aop16311.pdf)
91. Oliveira, C.D., Moreira, C.Q., de Sá, L.R., Spinosa, H. de S. and Yonamine, M. 2010. Maternal and developmental toxicity of ayahuasca in Wistar rats. Birth Defects Research. Part B, Developmental and Reproductive Toxicology, 89(3): 207-12.
92. Osório, F.L.; de Macedo, L.R.H.; de Sousa, J.P.M.; Pinto, J.P.; Quevedo, J.; Crippa, J.A.S. & Jaime Eduardo C. Hallak, J.E.C. 2011. The therapeutic potential of harmine and ayahuasca in depression: evidence from exploratory animal and human studies. In: R.G. dos Santos (Ed.) The Ethnopharmacology of Ayahuasca. Trivandrum: Transworld Research Network. http://www.trnres.com/ebook/uploads/rafael/T_12998352185%20Rafael.pdf (http://www.trnres.com/ebook/uploads/rafael/T_12998352185%20Rafael.pdf)
93. Ott, J. 1994. Ayahuasca Analogues: Pangaean Entheogens, Kennewick: Natural Books Co.
94. Owaisat, S., Raffa, R.B. and Rawls, S.M. 2012. In vivo comparison of harmine efficacy against psychostimulants: Preferential inhibition of the cocaine response through a glutamatergic mechanism. Neuroscience Letters, 525(1): 12-06.
95. Perú21. 2012. Hallan cuerpo de estadounidense perdido en Madre de Dios [Body of lost North American was found in Madre de Rios]. http://peru21.pe/actualidad/hallan-cuerpo-estadounidense-perdido-madre-dios-2041873 (http://peru21.pe/actualidad/hallan-cuerpo-estadounidense-perdido-madre-dios-2041873)
96. Perú21. 2011. Francesa muere tras consumir ayahuasca [French woman dies after consuming ayahuasca]. http://peru21.pe/impresa/noticia/francesa-muere-consumir-ayahuasca/2011-08-10/310767 (http://peru21.pe/impresa/noticia/francesa-muere-consumir-ayahuasca/2011-08-10/310767)
97. Pilgrim, J.L., Gerostamoulos, D., Woodford, N. and Drummer, O.H. 2012. Serotonin toxicity involving MDMA (ecstasy) and moclobemide. Forensic Science International, 215(1-3): 184-88.
98. Pomilio, A.B., Vitale, A.A. and Ciprian-Ollivier, J. 2003. Cult-Hoasca: A model for schizophrenia. Molecular Medicinal Chemistry, 1: 1-7.
99. Pomilio, A.B., Vitale, A.A., Ciprian-Ollivier, J., Cetkovich-Bakmas, M., Gómez, R. and Vásquez, G. 1999. Ayahoasca: An experimental psychosis that mirrors the transmethylation hypothesis of schizophrenia. Journal of Ethnopharmacology, 65(1): 29-51.
100. Poulson, E. and Robson, J.M. 1963. The effect of amine oxidase inhibitors on pregnancy. Journal of Endocrinology, 27: 147-55.
101. Prado, D.A., Pinto, J., Crippa, J., Santos, A., Ribeiro, S., Araújo, D., Zuardi, A., Chaves, C. and Hallak, J. 2009. Effects of the Amazonian psychoactive plant beverage ayahuasca on prefrontal and limbic regions during a language task: A fMRI study. European Neuropsychopharmacology, 19(Suppl 3): S314-5.
102. Réus, G.Z., Stringari, R.B., Gonçalves, C.L., Scaini, G., Carvalho-Silva, M., Jeremias, G.C., Jeremias, I.C., Ferreira, G.K., Streck, E.L., Hallak, J.E., Zuardi, A.W., Crippa, J.A. and Quevedo, J. 2012. Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain. Depression Research and Treatment, 2012: Article ID 987397. doi:10.1155/2012/987397
103. Réus, G.Z., Stringari, R.B., de Souza, B., Petronilho, F., Dal-Pizzol, F., Hallak, J.E., Zuardi, A.W., Crippa, J.A. and Quevedo, J. 2010. Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus. Oxidative Medicine and Cellular Longevity, 3(5): 325-31.
104. Riba, J. 2003. Human pharmacology of Ayahuasca. Doctoral thesis, Universitat Autònoma de Barcelona, Barcelona, Spain. http://www.tdx.cesca.es/TDX-0701104-165104/ (http://www.tdx.cesca.es/TDX-0701104-165104/)
105. Riba, J. and Barbanoj, M.J. 2011. "Pharmacology of ayahuasca: Clinical trials in healthy volunteers". In The Internationalization of Ayahuasca, Edited by: Labate, B.C. and Jungaberle, H. Zurich/Berlin: Lit Verlag.
106. Riba, J. and Barbanoj, M.J. 2006. "Ayahuasca". In Tratado SET de Transtornos Adictivos, Edited by: Peris, J.C., Zurián, J.C., Martínez, G.C. and Valladolid, G.R. Madrid: Médica Panamericana.
107. Riba, J. and Barbanoj, M.J. 2005. Bringing ayahuasca to the clinical research laboratory. Journal of Psychoactive Drugs, 37(2): 219-30.
108. Riba, J., Rodríguez-Fornells, A. and Barbanoj, M.J. 2002. Effects of ayahuasca sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively. Psychopharmacology, 165(1): 18-28.
109. Riba, J., McIlhenny, E.H., Valle, M., Bouso, J.C. and Barker, S.A. 2012. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca. Drug Testing & Analysis, 4(7-8): 610-06.
110. Riba, J., Romero, S., Grasa, E., Mena, E., Carrió, I. and Barbanoj, M.J. 2006. Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant. Psychopharmacology, 186(1): 93-8.
111. Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A. and Barbanoj, M.J. 2004. Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: A functional neuroimaging study using low-resolution electromagnetic tomography. Neuropsychobiology, 50(1): 89-101.
112. Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A. and Barbanoj, M.J. 2003. Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics, 306(1): 73-83.
113. Riba, J., Anderer, P., Morte, A., Urbano, G., Jané, F., Saletu, B. and Barbanoj, M.J. 2002. Topographic pharmaco-EEG mapping of the effects of the South American beverage ayahuasca in healthy volunteers. British Journal of Clinical Pharmacology, 53(6): 613-28.
114. Riba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., Montero, M., Callaway, J.C. and Barbanoj, M.J. 2001. Subjective effects and tolerability of the South American psychoactive beverage ayahuasca in healthy volunteers. Psychopharmacology, 154(1): 85-95.
115. Roberts, C. 2012. Father of teen dead in Peru ritual thinks son was murdered. http://www.nbcbayarea.com/news/local/Father-of-Teen-Dead-in-Peru-Ritual-Thinks-Son-Was-Murdered-171382471.html (http://www.nbcbayarea.com/news/local/Father-of-Teen-Dead-in-Peru-Ritual-Thinks-Son-Was-Murdered-171382471.html)
116. RPP Noticias. 2012. Curandero confesó que enterró a joven norteamericano [Curandero confessed he had buried young American]. http://www.rpp.com.pe/2012-09-11-madre-de-dios-curandero-confeso-que-enterro-a-joven-norteamericano-noticia_520815.html (http://www.rpp.com.pe/2012-09-11-madre-de-dios-curandero-confeso-que-enterro-a-joven-norteamericano-noticia_520815.html)
117. RPP Noticias. 2010. Joven sueco quedó en coma tras probar Ayahuasca [Young Swede enters into coma after trying ayahuasca]. http://www.rpp.com.pe/2010-12-29-joven-sueco-quedo-en-coma-tras-probar-ayahuasca-noticia_323021.html (http://www.rpp.com.pe/2010-12-29-joven-sueco-quedo-en-coma-tras-probar-ayahuasca-noticia_323021.html)
118. Schultes, R.E. 1986. El desarrollo histórico de la identificación de las malpigiáceas empleadas como alucinógenos [The historical development of the identification of malpighiaceous used as hallucinogens]. América Indígena, 46(1): 9-47.
119. Schultes, R.E. and Hofmann, A. 1992. Plants of the Gods: Their Sacred, Healing, and Hallucinogenic Powers, Rochester: Healing Arts Press.
120. Selvaraj, S., Hoshi, R., Bhagwagar, Z., Murthy, N.V., Hinz, R., Cowen, P., Curran, H.V. and Grasby, P. 2009. Brain serotonin transporter binding in former users of MDMA ('ecstasy'). British Journal of Psychiatry, 194(4): 355-59.
121. Silins, E., Copeland, J. and Dillon, P. 2007. Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: Hierarchy of risk. Australian and New Zealand Journal of Psychiatry, 41(8): 649-55.
122. Sklerov, J., Levine, B., Moore, K.A., King, T. and Fowler, D. 2005. A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation. Journal of Analytical Toxicology, 29(8): 838-41.
123. 2C serotonin receptors. Pharmacology, Biochemistry and Behavior, 61(3): 323-30.
124. Stuckey, D.E., Lawson, R. and Luna, L.E. 2005. EEG gamma coherence and other correlates of subjective reports during ayahuasca experiences. Journal of Psychoactive Drugs, 37(2): 163-78.
125. Topping, D.M. 1998. Ayahuasca and cancer: One man's experience. MAPS Newsletter, 8 (3): 22-6. http://www.maps.org/news-letters/v08n3/08322top.html (http://www.maps.org/news-letters/v08n3/08322top.html)
126. UOL Notícias. 2009. Jovem morre após consumir chá de Santo Daime [Young man dies after consuming the Santo Daime tea]. http://noticias.uol.com.br/ultnot/multi/?hashId=go-jovem-morre-apos-consumir-cha-de-santo-daime-0402376ED8C97366&mediaId=379677 (http://noticias.uol.com.br/ultnot/multi/?hashId=go-jovem-morre-apos-consumir-cha-de-santo-daime-0402376ED8C97366&mediaId=379677)
127. Vanguardia. 2011. Dos personas murieron tras un ritual con yagé [Two people died after a ritual with yagé]. http://www.vanguardia.com/judicial/117420-dos-personas-murieron-tras-un-ritual-con-yage (http://www.vanguardia.com/judicial/117420-dos-personas-murieron-tras-un-ritual-con-yage)
128. Vera, G.H. 2010. Hombre que quería "arreglar su matrimonio", murió tomando yagé [Man who wanted to "fix his marriage", died drinking yagé]. http://www.elespacio.com.co/oficial/index.php/judicial/judicial/12842-hombre-que-queria-arreglar-su-matrimonio-murio-tomando-yage (http://www.elespacio.com.co/oficial/index.php/judicial/judicial/12842-hombre-que-queria-arreglar-su-matrimonio-murio-tomando-yage)
129. Vollenweider, F.X., Jones, R.T. and Baggott, M.J. 2001. Caveat emptor: Editors beware. Neuropsychopharmacology, 24(4): 461-63.
130. Vollenweider, F.X., Gamma, A., Liechti, M. and Huber, T. 1999. Is a single dose of MDMA harmless?. Neuropsychopharmacology, 21(4): 598-600.
131. Vuori, E., Henry, J.A., Ojanperä, I., Nieminen, R., Savolainen, T., Wahlsten, P. and Jäntti, M. 2003. Death following ingestion of MDMA (ecstasy) and moclobemide. Addiction, 98(3): 365-68.
132. Warren, R.J. 2004. Fatal nicotine intoxication resulting from the ingestion of "ayahuasca". Journal of Analytical Toxicology, 28: 287
133. Wu, C., Jiang, X.L., Shen, H.W. and Yu, A.M. 2009. Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model. Biochemical Pharmacology, 78(6): 617-24.
134. Yamada, M. and Yasuhara, H. 2004. Clinical pharmacology of MAO inhibitors: Safety and future. Neurotoxicology, 25(1-2): 215-21.
135. Youdim, M.B.H. and Weinstock, M. 2004. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation. Neurotoxicology, 25(1-2): 243-50.
136. Yritia, M., Riba, J., Ortuño, J., Ramirez, A., Castillo, A., Alfaro, Y., de la Torre, R. and Barbanoj, M.J. 2002. Determination of N,N-dimethyltryptamine and beta-carboline alkaloids in human plasma following oral administration of Ayahuasca. Journal of Chromatography B, 779(2): 271-81.
137. Yu, A.M., Idle, J.R., Krausz, K.W., Küpfer, A. and Gonzalez, F.J. 2003. Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic β-carboline alkaloids harmaline and harmine. Journal of Pharmacology and Experimental Therapeutics, 305(1): 315-22.
138. Zhao, T., Zheng, S.S., Zhang, B.F., Li, Y.Y., Bligh, S.W., Wang, C.H. and Wang, Z.T. 2012. Metabolic pathways of the psychotropic-carboline alkaloids, harmaline and harmine, by liquid chromatography/mass spectrometry and NMR spectroscopy. Food Chemistry, 134(2): 1096-105.
139. Zhao, T., He, Y.Q., Wang, J., Ding, K.M., Wang, C.H. and Wang, Z.T. 2011. Inhibition of human cytochrome P450 enzymes 3A4 and 2D6 by β-carboline alkaloids, harmine derivatives. Phytotherapy Research, 25(11): 1671-77.